IGF1R and malignant colon neoplasm: Recently, we demonstrated that IGF-1R kinase inhibitor PQIP causes marked antitumor activity in these colon cancer cell lines by abrogating the IGF-1R mediated activation of IRS1/Akt to inhibit survival signaling, and inducing apoptosis (10).